tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Balance Sheet

1,803 Followers

VYNE Therapeutics Balance Sheet

VYNE Therapeutics's total assets for Q4 2023 were $97.69M, an increase of 407.01% from the previous quarter. VYNE total liabilities were $8.95M for the fiscal quarter, a 15.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 97.69M$ 40.76M$ 67.05M$ 93.74M$ 79.17M
Total Liabilities
$ 8.95M$ 9.35M$ 18.41M$ 56.25M$ 10.66M
Total Equity Gross Minority
$ 88.77M$ 31.45M$ 48.64M$ 37.49M$ 68.51M
Total Capitalization
$ 88.83M$ 31.20M$ 85.07M$ 70.67M$ 68.51M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 1.61M$ 700.00K
Currency in USD

VYNE Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis